AIFA - Allergy and Immunology Foundation of Australasia

AIFA - ACNC Registered Charity

AIFA has awarded more than $620,000 in research grants to 27 projects since the program commenced in 2014. This includes:

  • $115,000 awarded to 4 research projects in 2022, announced at the ASCIA 2022 Conference, which included presentations by recipients of AIFA grants that were awarded in 2020.
  • $127,000 awarded to 5 research projects in 2021,  announced at the ASCIA 2021  Conference, which included presentations by recipients of AIFA grants that were awarded from 2015 to 2019.
  • $110,000 awarded to 5 research projects in 2020. 
  • $120,000 awarded to 5 research projects in 2019.

All research projects that have been awarded AIFA grants are listed on the AIFA website

AIFA grant rounds open in March and are announced at the ASCIA conference in September. Expression of interest (EOI) forms are on the AIFA website 

To be eligible for an AIFA grant the Chief Investigator must be an ASCIA member and the research needs to be carried out by the chief investigator and designated team in a non-profit institution in Australia or New Zealand. 

Thank you to the AIFA expert grant selection panel, led by Dr Melanie Wong, who volunteer their time to work on a robust selection process.

Thank you also to our generous AIFA donors and sponsors:  

By donating to AIFA or sponsoring an AIFA grant, you can be reassured that 100% of donations and sponsorship to AIFA directly fund allergy/immunology research grants. 

There are many projects with great potential that still require funding, so we seek your support for future AIFA grants.

Donate to AIFA now 

AIFA research grants encourage:

  • Emerging researchers who may not yet receive grants from the NHMRC or other organisations.
  • Innovative research that requires seed funding.
  • Collaborative research projects conducted throughout Australia and New Zealand.
  • Projects that will translate to better treatment and care for patients with allergy and other immune diseases.

pdfAIFA Leaflet1.06 MB

About AIFA

AIFA was established in 2013 by ASCIA, the peak professional body for allergy and clinical immunology in Australasia.  The aim of AIFA is to improve the health and care of people with allergy and other immune diseases by funding medical research  in Australia and New Zealand. 

Allergy and other immune system disorders (primary immunodeficiencies and autoimmune diseases) are amongst the most important chronic diseases and public health issues in Australia and New Zealand, affecting around 25% of the population. Funding of research into allergy and other immune diseases is vital for the prevention and treatment of these diseases, and to ultimately find cures.  

Content updated December 2022

Mod ASCIA Member
Donate to AIFA
go to NAC website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia